Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study

Table 3

Longitudinal evaluation of biochemical data of patients with CPP at baseline (diagnosis of CPP) and during GnRHa treatment.

	Baseline		1st follow-up visit		2nd follow-up visit
	Group A	Group C	Group A	Group C	Group A	Group C
LH (mUI/ml)	2.54 ± 2.23	0.49 ± 0.50^^	0.58 ± 0.56	0.28 ± 0.17	0.48 ± 0.55	0.28 ± 0.15
FSH (mUI/ml)	5.34 ± 5.96	3.44 ± 1.41	1.86 ± 1.78	0.78 ± 0.57	2.65 ± 2.18	0.47 ± 0.25
Oestradiol (pg/ml)	27.13 ± 16.92	12.65 ± 6.94^^	12.36 ± 6.72	11.93 ± 2.94	11.13 ± 3.02	11.28 ± 2.21

^{^}Significant difference between the groups at the specific time point.